CaliberCos Inc. financial data

Symbol
CWD on Nasdaq
Location
Scottsdale, AZ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -780% % 90%
Return On Equity -1436% % -10285%
Return On Assets -29% % -477%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 15,177,583 shares 9.4%
Entity Public Float $9,200,000 USD -65%
Weighted Average Number of Shares Outstanding, Basic 2,615,000 shares 136%
Weighted Average Number of Shares Outstanding, Diluted 2,615,000 shares 86%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $24,657,000 USD -63%
Revenue from Contract with Customer, Excluding Assessed Tax $15,700,000 USD -53%
General and Administrative Expense $1,471,000 USD 2.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $25,860,000 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $25,465,000 USD -137%
Earnings Per Share, Basic -2 USD/shares 64%
Earnings Per Share, Diluted -2 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,927,000 USD 596%
Assets $82,568,000 USD -48%
Liabilities $76,481,000 USD -20%
Retained Earnings (Accumulated Deficit) $70,684,000 USD -56%
Stockholders' Equity Attributable to Parent $4,183,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6,087,000 USD -90%
Liabilities and Equity $82,568,000 USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,738,000 USD -14%
Net Cash Provided by (Used in) Financing Activities $1,308,000 USD -75%
Net Cash Provided by (Used in) Investing Activities $107,000 USD 99%
Common Stock, Shares, Issued 15,177,583 shares 9.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $537,000 USD 96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13,388,000 USD 226%
Deferred Tax Assets, Valuation Allowance $11,703,000 USD 68%
Additional Paid in Capital $74,862,000 USD 81%
Interest Expense $5,180,000 USD 202%